JP Stock MarketDetailed Quotes
4565 Nxera Pharma
- 1556
- +6+0.39%
20min DelayMarket Closed Aug 15 15:00 JST
139.89BMarket Cap-17848P/E (Static)
1571High1545Low506.40KVolume1565Open1550Pre Close787.14MTurnover182652wk High0.76%Turnover Ratio89.90MShares129652wk Low-114.56EPS TTM104.17BFloat Cap6545Historical HighLossP/E (Static)66.95MShs Float23Historical Low-87.18EPS LYR1.68%Amplitude--Dividend TTM2.03P/B100Lot Size--Div YieldTTM
About Nxera Pharma Company
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein-Coupled Receptors (“GPCRs”).
Company Profile
Symbol4565
Company NameNxera Pharma
Founded1990-06-22
Employees348
Fiscal Year Ends12-31
AddressMidtown East 9-7-2 Akasaka Minato-ku
Zip Code102-0083
Phone03-5210-3290
Websitesoseiheptares.com
Company Executives
- Name
- Position
- Salary
- Christopher Cargill
- Director, President and Chief Executive Officer
- --
- Shinichi Tamura
- Chairman of the Board
- --
- Miwa Seki
- Independent Director
- --
- Eiko Tomita
- Independent Director
- --
- Tomohiro Tohyama
- Independent Director
- --
- Rolf Soderstrom
- Independent Director
- --
- Kuniaki Kaga
- Independent Director
- --
- Noriaki Nagai
- Independent Director
- --
- David Roblin
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
% Chg